Position Summary
We are seeking an innovative and highly motivated Process Owner who will contribute significantly to the development and continued growth of our advanced cell therapy manufacturing platform.
The Process Owner will play a pivotal role in driving the successful adoption of our automated Cell Therapy Manufacturing Platform by engaging with partners and clients throughout the product adoption life cycle. The Process Owner will be responsible for establishing strong working relationships, understanding customer needs, and delivering tailored solutions to maximize customer satisfaction and adoption success.
This is a multidisciplinary role responsible for interfacing across many parts of the company (with Process and Analytical Development, MSAT, Product and Alliance Management teams) to develop the best solutions possible.
Candidates should enjoy working in a fast-paced, mission-driven environment, and be prepared to tackle a broad selection of challenges as the company grows.
Annual Salary Range: $90,000 - $210,000
Cellares total compensation package contains competitive base salaries, highly subsidized Medical, Dental, and Vision Plans, 401(k) Matching, Free EV Charging, Onsite lunches, and Stock options. All displayed pay ranges are approximate, negotiable, and location dependent.
This is Cellares
Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century. The company is both developing and operating integrated technologies for cell therapy manufacturing to accelerate access to life-saving cell therapies. The company’s Cell Shuttle integrates all the technologies required for the entire manufacturing process in a flexible and high-throughput platform that delivers true walk-away, end-to-end automation. Cell Shuttles will be deployed in Cellares’ Smart Factories around the world to meet total patient demand for cell therapies at global scale. Partnering with Cellares enables academics, biotechs, and pharma companies to accelerate drug development and scale out manufacturing, lower process failure rates, lower manufacturing costs, and meet global patient demand.
The company is headquartered in South San Francisco, California with its commercial-scale IDMO Smart Factory in Bridgewater, New Jersey. The company is backed by world-class investors and has raised over $355 million in financing.
Leveling will be based on overall experience, education, and demonstration of knowledge throughout the interview process.